He Huiqing, Liu Rang, Zhang Qiuju, Geng Lan, Hou Zhenhui, Xu Chang, Cao Yanpei, Xia Xi
Center for Reproductive Medicine, Peking University Shenzhen Hospital, No. 1120 Lotus Road, Futian District, Shenzhen, 518036, Guangdong, China.
Shantou University Medical College, Shantou, 515000, Guangdong, China.
Arch Gynecol Obstet. 2025 Feb;311(2):507-517. doi: 10.1007/s00404-024-07850-2. Epub 2024 Dec 16.
For unexpected low-prognosis patients (Group 1 and Group 2) defined by POSEIDON criteria, how to maximize the live birth rate while controlling the multiple birth rate by tailoring the embryo transfer number and quality?
This was a retrospective study, including patients from Poseidon Group 1 (N = 672) and Group 2 (N = 503) who underwent cleavage-stage embryo transfer. Logistic regression was used for the comparative analysis of clinical outcomes among subgroups divided by the number and quality of embryos.
For Group 1, compared to transferring a single good-quality embryo (GQE), a good-quality embryo with a poor-quality embryo (GQE + PQE) did not significantly improve the live birth rate, although increasing in value (40.5% vs 31.9%, P = 0.272), meanwhile obviously raised the multiple birth rate to 28.1% (P = 0.042). For Group 2, double embryo transfer (DET) was associated with a higher live birth rate than single embryo transfer (SET) (22.4% vs 6.3%, P = 0.001) and further analysis indicated that the similar trend observed in the GQE + PQE group compared to the GQE group (26.1% vs 8.5%, P = 0.017) with statistical significance, but without a significant increase in the multiple birth rate (8.3%, P = 1.000).
The study indicated that a single good-quality cleavage-stage embryo was an option for patients in Poseidon Group 1 to avoid the risk of multiple pregnancies. DET with mixed quality cleavage-stage embryo might be an alternative for Poseidon Group 2, given that it improved the pregnancy outcomes while controlling the multiple birth rates.
对于由波塞冬标准定义的意外低预后患者(第1组和第2组),如何通过调整胚胎移植数量和质量来在控制多胎率的同时最大化活产率?
这是一项回顾性研究,纳入了接受卵裂期胚胎移植的波塞冬第1组(N = 672)和第2组(N = 503)患者。采用逻辑回归对按胚胎数量和质量划分的亚组间临床结局进行比较分析。
对于第1组,与移植单个优质胚胎(GQE)相比,移植一个优质胚胎和一个劣质胚胎(GQE + PQE)虽然活产率有所提高(40.5%对31.9%,P = 0.272),但并未显著提高,同时多胎率明显升至28.1%(P = 0.042)。对于第2组,双胚胎移植(DET)的活产率高于单胚胎移植(SET)(22.4%对6.3%;P = 0.001),进一步分析表明,与GQE组相比,GQE + PQE组观察到类似趋势(26.1%对8.5%,P = 0.017),具有统计学意义,但多胎率无显著增加(8.3%,P = 1.000)。
该研究表明,对于波塞冬第1组患者,移植单个优质卵裂期胚胎是避免多胎妊娠风险的一种选择。对于波塞冬第2组,移植质量混合的卵裂期胚胎进行双胚胎移植可能是一种替代方案,因为它在控制多胎率的同时改善了妊娠结局。